RBM15 and gastric adenocarcinoma: Strikingly, RBM15 RNA did not show a negative correlation with immune cell infiltration in liver hepatocellular carcinoma (LIHC), pancreatic adenocarcinoma (PAAD), or stomach adenocarcinoma (STAD) (Supplementary Figures S1A-F).